Health Technology, Healthcare Analytics

AscellaHealth's Specialty & Rare Pipeline Digest™: FDA Approval Status for Specialty Drug Product Launches and Cell & Gene Therapies Unveiled

ascellahealths-specialty-and

AscellaHealth, a global healthcare and specialty pharmacy solutions organization, today released its Q2 2023 Specialty & Rare Pipeline Digest™, the industry’s most comprehensive resource on new, pending and projected Specialty and Rare Disease drug launches, and cell and gene therapies, biosimilars and generics. This complimentary, valuable source of industry information supports the specialty drug market needs of stakeholders and decision-makers including pharmaceutical manufacturers, payers and providers, with essential updates on products that are making an impact for millions of individuals living with or affected by rare disease or complex chronic conditions.

“As an industry-leading, global healthcare and specialty pharmacy solutions organization, my team researched, annotated and compiled these critically important updates, timely information, statistics and facts to support our clients and partners and other industry stakeholders,” says Andy Szczotka, PharmD, chief pharmacy officer, AscellaHealth.

Dea Belazi, president & CEO, AscellaHealth, adds, “We are proud to empower all market stakeholders with key data and insights that guide the industry. The dedicated work of pharmaceutical manufacturers to launch innovative therapies complemented by the efforts of payers and providers to ensure affordability and treatment availability are so commendable.”

AscellaHealth provides end-to-end, customized solutions to all industry stakeholders, namely patients, life sciences manufacturers, payers and providers to improve medication access, optimize clinical outcomes and enhance the patient journey. Services include:

  • Pre-Commercialization & Market Access
  • Exclusive Distribution, Wholesale, and 3PL Services
  • International Specialty Pharmacy Fulfillment including Limited Distribution Drugs
  • Comprehensive HUB and Patient Support Services
    • Custom Compliance and Persistency Programs
    • Streamlined Prior Authorizations
    • Technology-based Patient Engagement
    • Integrated Copay and Financial Assistance Programs
  • Real-time Rx Data and Analytics

Specialty Pharmacy & Medical Benefit Management

About AscellaHealth LLC

AscellaHealth, a global Healthcare & Specialty Pharmacy solutions organization, serving patients, life sciences manufacturers, payers and providers, offers a comprehensive portfolio of uniquely tailored, tech-enabled services supporting complex, chronic conditions or rare diseases that require specialty medications and/or cell and gene therapies. A recipient of numerous industry awards for innovation, and a NASP Strategic Channel Partner of the Year award winner, AscellaHealth’s best-in-class, patient-centric approach is built upon proprietary technology processes for novel programs and services to support the launch of specialty medications and proactively address multiple challenges, optimize clinical health outcomes, and improve quality of life for this patient population.

Spotlight

Spotlight

Related News

Health Technology, Digital Healthcare

Launch of RICOH Remote Patient Monitoring Enablement Designed to Help Ease Healthcare Staffing Challenges Amid Unprecedented Industry Burnout Crisis

PR Newswire | October 06, 2023

Ricoh USA, Inc. announces the launch of RICOH Remote Patient Monitoring (RPM) Enablement, the newest end-to-end managed services offering for health systems that is designed to help fuel more efficient and sustainable RPM workflows that can lead to improved patient and care delivery team experiences. RICOH RPM Enablement comes at a time when health systems are grappling with a simultaneous monumental shift to virtual care delivery and an unprecedented shortage of healthcare workers. This care worker shortage has reached a nationwide crisis level where there aren't nearly enough healthcare staff to fill vital RPM management roles, leading to alarming care gaps impacting the most vulnerable patient populations. RICOH RPM Enablement is designed to help health systems close this gap and to help lead to improved patient experiences by integrating into existing virtual care programs to support the deployment of remote patient monitoring system devices, inventory tracking, logistics, and device returns. The healthcare worker burnout and staffing shortage – most recently worsened by COVID – is putting extraordinary constraints on health systems to staff RPM management roles, which limits their ability to scale virtual programs and impacts the standard of patient care. According to the Surgeon General, 98% of healthcare workers worry about their own burnout1, which is likely accelerating nurse retirement, fueling a shortfall of 1.1 million registered nurses1. The Mayo Clinic's research has also revealed that U.S. doctor burnout has reached an all-time high of 63%2. Additionally, 98% of clinicians are concerned that burnout can reduce quality of care and 82% of the public believes that a worker shortage will impact their health3. Technology can be the difference maker in systemic change – and clinicians agree as 50-70% welcome the change to use technologies in their work4. "Clinicians currently spend over 50% of their working hours using EHRs5. That's their reality and a massive contributor to burnout, so our mission is centered on pivoting that time back to patient care through supporting the modernization, automation, and enablement of the care workflows that are most critical to health system's success," said Rory Fitzpatrick, Vice President, Industry Vertical Marketing, Ricoh North America. RPM Enablement is the latest demonstration of our commitment. In this period of burnout crisis, the healthcare industry has an opportunity to commit to workers' emotional and physical wellbeing – and Ricoh is dedicated to supporting positive systemic change with sustainable, scalable solutions. [Source: PR Newswire] RPM is often considered one of the largest value drivers of virtual care with applications from primary care through chronic disease management. In fact, when RPM is part of a care plan, the Mayo Clinic has shown that 72.5% of remote patient monitoring patients comply with the care plan's tasks, including taking medications and monitoring vitals6. Further, only 9.4% were readmitted within 30 days versus 20% of patients not using RPM6. Ricoh is uniquely positioned to help address workflow challenges resulting from the qualified healthcare worker shortage due to its large footprint and depth of managed services experience in the industry. Ricoh currently supports thousands of healthcare organizations with various aspects of their business, including 9 out of 11 of the largest for-profit hospital systems and 22 out of 32 of the largest nonprofit hospital systems, with about 3,200 facilities under its support – and is also responsible for managing over 1 million devices in the United States through more than 2,100 U.S. field technicians across various industries.

Read More

Health Technology, Medical Devices

GE HealthCare Receives FDA Clearance of Allia IGS Pulse - the Next Generation of Image-Guided Systems Designed for Cardiac Imaging Excellence

Business Wire | October 18, 2023

GE HealthCare announced US FDA 510(k) clearance of Allia IGS Pulse - the latest addition to the company’s image guided system (IGS) offerings. Allia IGS Pulse features a new imaging chain engineered to provide exceptional imaging at the right dose for visible impact in complex cardiology interventions regardless of patient size. In modern healthcare today, cardiovascular disease (CVD) continues to grow in prevalence, with CVDs being the leading cause of death globally. As clinicians work to treat CVDs, cardiology procedures continue to evolve as demand for minimally invasive surgery grows. GE HealthCare is committed to helping interventional cardiologists, vascular surgeons and other interventional specialists use image guidance technologies to their full potential by optimizing workflows and providing exceptional image quality to help clinicians provide quality care to their patients, while also enabling better clinical and operational outcomes. According to a survey of interventionalists, nearly 50% of interventional procedures are performed at working positions where clinicians have poor access to user interface functions and display.3 Designed to address these challenges, the new Allia IGS Pulse provides a personalized workspace that meets the operator’s specific needs and preferences. As part of its new image chain, the system features the first monopolar x-ray tube used to capture images for interventional procedures. This new tube is powerful, yet quieter than normal conversation4 to optimize the operating environment during a procedure. The small footprint of the new tube also helps clinicians reach steep angulation for better understanding of coronary artery anatomy, even with the 30cm detector configurations. The latest version of MyIQ technology incorporated into the system allows clinicians to select their favorite image look from four different image styles with just one click for a tailored experience at no additional dose. In the treatment of complex cardiovascular diseases, image quality and optimized dose management regardless of patient size are also important to clinicians. With Allia IGS Pulse, interventionalists are able to get exceptional image quality for large and bariatric patients with a BMI of greater than 30. The system’s reduced pulse width and unmatched X-ray peak power helps to decrease motion blur for better visualization of moving elements such as vessels and devices. To relieve clinicians and technologists of the complex task of optimizing image quality and dose during procedures, Allia IGS Pulse takes AutoRight, the company’s intelligent image chain leveraging AI, a step further with AutoRight PLUS - the next generation of the automation platform. With AutoRight PLUS, the system now optimizes seven parameters in real time, including Focal Spot Shape. By removing the burden of manual adjustment during procedures, clinicians can stay focused on the procedure and treatment of their patients. To further optimize dose along the image chain, a unique suite of tools is also available to help support dose efficiency, dose reduction and dose awareness. Since January 2023, Allia IGS Pulse has been in pilot operations at Clinique Pasteur - Toulouse in Toulouse, France. “At Clinique Pasteur in Toulouse, we perform thousands of interventional cardiology procedures each year,” says Dr. Nicolas Dumonteil, Interventional Cardiologist, Clinique Pasteur, Toulouse. “As an operator of the Allia IGS Pulse system, I felt a significant and real improvement in the imaging quality, as well as a significant reduction of this noise in my daily procedures which gave me great confidence and comfort in the operating room. The system is also quite adaptable and versatile to all of my daily situations and procedures – from percutaneous coronary interventions (PCIs) to other complex and structural ones.” says Dr Raphaël Philippart, Interventional Cardiologist, Clinique Pasteur, Toulouse. I saw a significant improvement in the image quality, especially with obese patients and complex angioplasties - where a good visibility of my guidewire, balloons and stents are particularly important. [Source – Business Wire] “Interventional cardiology procedures require exceptional image quality,” says Arnaud Marie – General Manager of Interventional for GE HealthCare. “I’m excited by the addition of Allia IGS Pulse to our interventional offerings because it addresses the very things clinicians continue to tell us present challenges in their day-to-day practice. By developing new features to further evolve our core platform, we’re helping to reduce complexity and improve the operating environment so that clinicians can have a personalized workspace that better enables them to keep their focus where it belongs – on their patients.”

Read More

Health Technology, Digital Healthcare

Best Buy Health and Geisinger Enhance Home Chronic Disease Management

Geisinger | September 13, 2023

Collaborating with Best Buy's Geek Squad ensures faster care, better adherence, and superior outcomes for chronic care patients. In 2021, Geisinger launched ConnectedCare365, enrolling over 1,100 patients in remote monitoring for various chronic conditions via Best Buy Health's Current Health platform. In July 2022, Best Buy Health and Geisinger began a program with Geek Squad Agents to deliver and activate remote care management devices. Best Buy Health and Geisinger have announced their commitment to expand their collaborative efforts to enhance the quality of care for a broader patient population within the Geisinger network. This expansion builds upon their successful delivery of in-home care to patients with chronic conditions through Geek Squad. This initiative currently encompasses 300 Geisinger patients. During their home visits, these agents critically educate patients about the technology integral to their care plan. They offer detailed explanations about the devices, instruct patients on proper usage, and ensure seamless data transmission to the patient's care team. Additionally, agents are available to help with troubleshooting as needed, and they oversee the collection and processing of all devices after a patient leaves the program, following the care team's instructions. The program has achieved a remarkable 50% reduction in the time it takes for a patient to go from admission into the chronic care at-home program to the completion of device setup. This pivotal shift has seen the period shrink from an average of 96 hours to just 48 hours. Furthermore, patients' adherence to their care plans has improved by a commendable 19%, evident in their consistent use of remote technology equipment. Additionally, there has been an 18% decline in reported technical issues, and when replacements were necessary, Geek Squad agents swiftly provided new devices within 24 hours of receiving reports. These exceptional results have garnered positive patient feedback, with a net promoter score of 89 when asked about their experience with Geek Squad's home visits for chronic care program setup. Deborah Di Sanzo, President of Best Buy Health, stated, The results of our program show that when we combine what Best Buy is known for—technology support and expertise—with Geisinger's best-in-class care teams and network of clinics and hospitals, we can make a meaningful difference in the patient and caregiver experience. [Source: Business Wire] Additionally, she emphasized Geisinger's outstanding performance on this initiative. She expressed strong enthusiasm for expanding these capabilities nationwide, in alignment with Best Buy Health's mission to promote accessible at-home care for everyone. Karen Murphy, EVP, Chief Innovation Officer and Founding Director of the Steele Institute for Health Innovation at Geisinger, emphasized the dynamic changes in healthcare. She highlighted the organization's heightened dedication to bringing care closer to patients and members while striving to establish higher care quality standards. The collaboration with Best Buy Health has enabled Geisinger to reshape the healthcare experience, ushering in positive transformations in care delivery and reception. Best Buy aims to enhance lives through technology by providing customers with expert guidance, a diverse product range, and comprehensive in-store and online services. Meanwhile, Geisinger dedicates itself to simplifying the journey to improved health for its extensive community of over one million individuals.

Read More